Clinical utility of ambulatory blood pressure: perspectives for national insurance coverage
- 1 February 2002
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Blood Pressure Monitoring
- Vol. 7 (1), 27-31
- https://doi.org/10.1097/00126097-200202000-00005
Abstract
During 2001, the Center for Medicare and Medicaid Services (CMS, formally known as HCFA) independently evaluated the US national insurance coverage policy for ambulatory blood pressure monitoring. Diagnostic uses evaluated included screening for white-coat hypertension, assessment for possible antihypertensive drug resistance, evaluation of hypotensive symptoms, episodic hypertension, and autonomic dysfunction. In their analysis, the committee presented and analyzed the relevant scientific and clinical literature on the use of ABPM in certain patient populations and delineated the reason for a limited national coverage decision for patients with suspected white-coat hypertension.Keywords
This publication has 3 references indexed in Scilit:
- Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic HypertensionCirculation, 2000
- Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general populationJournal Of Hypertension, 2000
- Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.Hypertension, 1994